Despite a slight improvement in revenue growth forecasts, China Vanke’s consensus price target has been marginally revised down to CN¥6.80.
What's in the News
- China Vanke's board meeting is scheduled to consider and approve interim results for the six months ended 30 June 2025.
- The company issued earnings guidance, projecting a net loss attributable to shareholders of RMB 10,000 million to RMB 12,000 million for the first half of 2025, citing significant declines in project settlements, low gross margins, increased asset impairment provisions, and losses on bulk and equity transactions.
- The AGM approved amendments to the Articles of Association, abolishing the supervisory committee and transferring its responsibilities to the audit committee.
Valuation Changes
Summary of Valuation Changes for China Vanke
- The Consensus Analyst Price Target has fallen slightly from CN¥6.99 to CN¥6.80.
- The Consensus Revenue Growth forecasts for China Vanke has risen slightly from -18.6% per annum to -17.9% per annum.
- The Future P/E for China Vanke remained effectively unchanged, moving only marginally from 7.71x to 7.81x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.